Search

Your search keyword '"Tomioka, Hiromi"' showing total 306 results

Search Constraints

Start Over You searched for: Author "Tomioka, Hiromi" Remove constraint Author: "Tomioka, Hiromi"
306 results on '"Tomioka, Hiromi"'

Search Results

1. A randomized double-blind placebo-controlled trial of an inhibitor of plasminogen activator inhibitor-1 (TM5614) in mild to moderate COVID-19

2. Validation of a computed tomography diagnostic model for differentiating fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis

8. 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease

10. Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pulmonary fibrosis: a prospective observational study

15. Diagnostic Criteria Arrangement in Nationwide All ILD Registry with Central MDD in Japan; PROMISE study

24. Palliative care for interstitial lung disease: A nationwide survey of pulmonary specialists

25. Design and rationale of the Japanese Idiopathic Interstitial Pneumonias (JIPS) Registry

32. Essential Features of an Interstitial Lung Disease Multidisciplinary Meeting: An International Delphi Survey

36. Late Breaking Abstract - Long-term Effect of Pulmonary Rehabilitation under Nintedanib treatment in Idiopathic Pulmonary Fibrosis (FITNESS study)

38. Long-term effect of pulmonary rehabilitation in idiopathic pulmonary fibrosis: a randomised controlled trial

39. Additional file 1 of Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pulmonary fibrosis: a prospective observational study

40. Pneumonia Caused by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza Virus: A Multicenter Comparative Study

43. Molecular characteristics of serotype 3 Streptococcus pneumoniae isolates among community-acquired pneumonia patients in Japan

45. Additional file 1 of Prediction of patients with a tumor proportion score > 50% who do not respond to first-line monotherapy with pembrolizumab

47. Diagnosis and treatment of new idiopathic interstitial pneumonias cases: Analysis using the Japanese Registry

48. Prediction of patients with a tumor proportion score >50% who do not respond to first-line monotherapy with pembrolizumab

49. Prediction of patients with a tumor proportion score >50% who do not respond to first-line monotherapy with pembrolizumab

Catalog

Books, media, physical & digital resources